Electronic medical records as a tool in clinical pharmacology: Opportunities and challenges

Clinical Pharmacology and Therapeutics

Volumn 91, Issue 6, 2012, Pages 1083-1086

  Roden, D M ^a   Xu, H ^a   Denny, J C ^a   Wilke, R A ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PHARMACOLOGY; DRUG RESPONSE; ELECTRONIC MEDICAL RECORD; GENETIC ASSOCIATION; PHARMACOGENOMICS; PHENOTYPE; PRIORITY JOURNAL;

ELECTRONIC HEALTH RECORDS; GENETICS; HUMANS; PHARMACOGENETICS; PHARMACOLOGY, CLINICAL; PHENOTYPE; UNITED STATES;

EID: 84861344364     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2012.42     Document Type: Article

References (40)

1. Blumenthal, D. Wiring the health system-origins and provisions of a new federal program. N. Engl. J. Med. 365, 2323-2329 (2011).
2. McCarty, C.A. et al. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med. Genomics 4, 13 (2011).
3. Toh, S., Platt, R., Steiner, J.F. & Brown, J.S. Comparative- effectiveness research in distributed health data networks. Clin. Pharmacol. Ther. 90, 883-887 (2011).
4. Platt, R. et al. Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics. Pharmacoepidemiol. Drug Saf. 10, 373-377 (2001). (Pubitemid 33138456)
5. Dexter, P.R., Perkins, S.M., Maharry, K.S., Jones, K. & McDonald, C.J. Inpatient computer-based standing orders vs physician reminders to increase influenza and pneumococcal vaccination rates: a randomized trial. JAMA 292, 2366-2371 (2004). (Pubitemid 39491921)
6. Ko, Y. et al. Practitioners' views on computerized drug-drug interaction alerts in the VA system. J. Am. Med. Inform. Assoc. 14, 56-64 (2007). (Pubitemid 44909483)
7. Neilson, E.G. et al. The impact of peer management on test-ordering behavior. Ann. Intern. Med. 141, 196-204 (2004).
8. Waitman, L.R. et al. Adopting real-time surveillance dashboards as a component of an enterprisewide medication safety strategy. Jt. Comm. J. Qual. Patient Saf. 37, 326-332 (2011).
9. Frisse, M.E. et al. The financial impact of health information exchange on emergency department care. J. Am. Med. Inform. Assoc. 19, 328e333 (2012).
10. Brownstein, J.S., Sordo, M., Kohane, I.S. & Mandl, K.D. The tell-tale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction. PLoS ONE 2, e840 (2007).
11. Behrman, R.E., Benner, J.S., Brown, J.S., McClellan, M., Woodcock, J. & Platt, R. Developing the Sentinel System-a national resource for evidence development. N. Engl. J. Med. 364, 498-499 (2011).
12. Ginsberg, J., Mohebbi, M.H., Patel, R.S., Brammer, L., Smolinski, M.S. & Brilliant, L. Detecting influenza epidemics using search engine query data. Nature 457, 1012-1014 (2009).
13. Tatonetti, N.P. et al. Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels. Clin. Pharmacol. Ther. 90, 133-142 (2011).
14. McCarty, C.A., Nair, A., Austin, D.M. & Giampietro, P.F. Informed consent and subject motivation to participate in a large, population-based genomics study: the Marshfield Clinic Personalized Medicine Research Project. Community Genet. 10, 2-9 (2007). (Pubitemid 46005795)
15. Roden, D.M. et al. Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin. Pharmacol. Ther. 84, 362-369 (2008).
16. Aberdeen, J. et al. The MITRE Identification Scrubber Toolkit: design, training, and assessment. Int. J. Med. Inform. 79, 849-859 (2010).
17. Pulley, J., Clayton, E., Bernard, G.R., Roden, D.M. & Masys, D.R. Principles of human subjects protections applied in an opt-out, de-identified biobank. Clin. Transl. Sci. 3, 42-48 (2010).
18. Wilke, R.A., Berg, R.L., Vidaillet, H.J., Caldwell, M.D., Burmester, J.K. & Hillman, M.A. Impact of age, CYP2C9 genotype and concomitant medication on the rate of rise for prothrombin time during the first 30 days of warfarin therapy. Clin. Med. Res. 3, 207-213 (2005).
19. Ritchie, M.D. et al. Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. Am. J. Hum. Genet. 86, 560-572 (2010).
20. Wilke, R.A. et al. Use of an electronic medical record for the identification of research subjects with diabetes mellitus. Clin. Med. Res. 5, 1-7 (2007). (Pubitemid 350218773)
21. Meystre, S.M., Savova, G.K., Kipper-Schuler, K.C. & Hurdle, J.F. Extracting information from textual documents in the electronic health record: a review of recent research. Yearb. Med. Inform. 128-144 (2008).
22. Kurreeman, F. et al. Genetic basis of autoantibody positive and negative rheumatoid arthritis risk in a multi-ethnic cohort derived from electronic health records. Am. J. Hum. Genet. 88, 57-69 (2011).
23. Kohane, I.S. Using electronic health records to drive discovery in disease genomics. Nat. Rev. Genet. 12, 417-428 (2011).
24. Liu, M. et al. Modeling drug exposure data in electronic medical records: an application to warfarin. AMIA Annu. Symp. Proc. 2011, 815-823 (2011).
25. Delaney, J.T. et al. Predicting clopidogrel response using DNA samples linked to an electronic health record. Clin. Pharmacol. Ther. 91, 257-263 (2012).
26. Xu, H. et al. Facilitating pharmacogenetic studies using electronic health records and natural-language processing: a case study of warfarin. J. Am. Med. Inform. Assoc. 18, 387-391 (2011).
27. Peissig, P. et al. Construction of atorvastatin dose-response relationships using data from a large population-based DNA biobank. Basic Clin. Pharmacol. Toxicol. 100, 286-288 (2007). (Pubitemid 46435086)
28. Denny, J.C. et al. Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome-and phenome-wide studies. Am. J. Hum. Genet. 89, 529-542 (2011).
29. Kho, A.N. et al. Electronic medical records for genetic research: results of the eMERGE consortium. Sci. Transl. Med. 3, 79re1 (2011).
30. Crosslin, D.R. et al. Genetic variants associated with the white blood cell count in 13,923 subjects in the eMERGE Network. Hum. Genet. 131, 639-652 (2012).
31. Kullo, I.J. et al. Complement receptor 1 gene variants are associated with erythrocyte sedimentation rate. Am. J. Hum. Genet. 89, 131-138 (2011).
32. Mangravite, L.M. et al. Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin. Arterioscler. Thromb. Vasc. Biol. 30, 1485-1492 (2010).
33. Thompson, J.F. et al. Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort. Circ. Cardiovasc. Genet. 2, 173-181 (2009).
34. Onitilo, A.A. et al. Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy. Breast Cancer Res. Treat. 115, 643-650 (2009).
35. Ramirez, A.H. et al. Predicting warfarin dosage in European-American and African-American subjects using DNA samples linked to an electronic health record. Pharmagenomics 13, 407-418 (2012).
36. Wilke, R.A. et al. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat. Rev. Drug Discov. 6, 904-916 (2007). (Pubitemid 350042398)
37. Ghebranious, N., McCarty, C.A. & Wilke, R.A. Clinical phenome scanning. Pers. Med. 4, 175-182 (2007). (Pubitemid 46845897)
38. Denny, J.C. et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics 26, 1205-1210 (2010).
39. Loukides, G., Gkoulalas-Divanis, A. & Malin, B. Anonymization of electronic medical records for validating genome-wide association studies. Proc. Natl. Acad. Sci. USA 107, 7898-7903 (2010).
40. Pulley, J.M. et al. Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project. Clin. Pharmacol. Ther. (in press).